Generated by AI
Amgen Inc. Common Stock represents ownership in Amgen Inc., a biotechnology company focused on discovering, developing, manufacturing, and marketing human therapeutics for serious diseases. The company’s portfolio spans therapies used in oncology, inflammation, cardiovascular conditions, osteoporosis, and rare diseases, making it a significant participant in global biopharmaceutical markets. Amgen also supports its business through biologic manufacturing capabilities and a commercial organization that brings prescription medicines to patients and healthcare providers in multiple regions. As a large-cap healthcare equity, Amgen Inc. Common Stock is widely followed by market participants for its role in the biotechnology sector and its exposure to branded medicines, biologics, and specialty treatment areas.
WebsiteOne Amgen Center Drive
Thousand Oaks, CA, 91320-1799
United States
The latest articles about AMGN.
Dow Jones biotech giant Amgen stock is trading in a buy zone following its recent breakout move amid the ongoing market weakness.
Summary of Nov 17's posts. Generated by AI.
Summary of Nov 3's posts. Generated by AI.
Summary of Mar 14's posts. Generated by AI.
Summary of Nov 3's posts. Generated by AI.
Investors talking about AMGN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.